
Person deep dive
Michael Dybbs
#47 2026 Strebulaev–Jackson Venture Ranking, emerging firms
Mike Dybbs is a partner at Samsara BioCapital, the Palo Alto life sciences investor, and has been there since its first fund in 2017. Before that he sat on the board of Principia Biopharma for New Leaf Venture Partners; Sanofi bought the company in 2020.
- Education
- University of California, Berkeley, Harvard University
Track record
Investments Michael Dybbs is best known for, with what became of them.
Principia BiopharmaBoard member for New Leaf Venture PartnersAcquired by Sanofi in 2020
Advanced Cell DiagnosticsBoard member for New Leaf Venture PartnersAcquired by Bio-Techne in 2016
Sutro BiopharmaBoard member for Samsara since 2018Listed on Nasdaq in 2018
Nkarta TherapeuticsBoard member for SamsaraListed on Nasdaq in 2020
Dimension TherapeuticsBoard member for New Leaf Venture PartnersAcquired by Ultragenyx in 2017
Samsara BioCapital
FirmSamsara BioCapital
Founded2016
Based inPalo Alto
FundsRaised $260.6M toward a $300M first fund by 2018, per an SEC filing
FocusLife sciences, from seed rounds to public equities
Career
- 2009Joined New Leaf Venture Partners after working as a principal at Boston Consulting Group; he became a partner and sat on the boards of Principia, Versartis and Dimension Therapeutics.
- 2017Joined Samsara BioCapital as a partner when the firm launched its first fund.
- 2018Joined the board of Sutro Biopharma, which listed on Nasdaq the same year.
Sources: Biocom: Mike Dybbs, Samsara BioCapital · Sutro Biopharma: Michael Dybbs · Venture Capital Journal: Samsara BioCapital raises $260.6M · Dealroom: Mike Dybbs. Rank: 2026 Strebulaev–Jackson Venture Ranking.
Currently
Active roles, board seats and partnerships.

Samsara BioCapital

Versartis
$330M valuation (2014)
→
Work history
Past roles by Dealroom records.

Principia BioPharma
$3.7B valuation (2020)Unicorn
→

Advanced Cell Diagnostics
$250M valuation (2016)
→

New Leaf Venture Partners

Boston Consulting Group
Education

University of California, Berkeley

Harvard University